By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AlphaVax, Inc. 

P.O. Box 110307
2 Triangle Drive
Research Triangle Park  North Carolina  27709-0307  U.S.A.
Phone: 919-595-0400 Fax: 919-595-0401



Company News
Harrisvaccines Secures Exclusive Rights From AlphaVax, Inc. to Develop RNA Particle Vaccines for All Diseases in Companion Animals 10/29/2013 10:41:54 AM
AlphaVax, Inc. Announces Nomination for 2012 Vaccine Industry Excellence Award 3/21/2012 9:43:44 AM
AlphaVax, Inc. Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine 7/19/2009 10:49:26 PM
AlphaVax, Inc. Announces Full Enrollment in Phase I/II Study of Active Immunotherapy in Patients with Advanced or Metastatic Cancer 5/14/2009 9:44:56 AM
AlphaVax, Inc. Announces Promising Results in Melanoma Studies 5/13/2009 9:21:10 AM
Novartis AG (JOBS) Licenses Vaccine Candidates from US Group, AlphaVax, Inc. for $20 Million 12/29/2008 7:55:11 AM
AlphaVax, Inc. Receives Conditional Approval to List on the TSX Venture Exchange 8/13/2008 10:46:52 AM
AlphaVax, Inc. Announces Initiation of Chlamydia Vaccine Program 7/21/2008 10:27:40 AM
AlphaVax, Inc. Continues to Expand the Use of Its Vaccine Platform 6/6/2008 11:15:00 AM
AlphaVax, Inc. Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial 4/17/2008 7:55:51 AM